Apellis Pharmaceuticals Inc (APLS)
24.27
-0.01
(-0.04%)
USD |
NASDAQ |
Mar 28, 16:00
24.28
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Total Assets (Quarterly): 885.05M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Macrogenics Inc | 261.66M |
| Salarius Pharmaceuticals Inc | 3.023M |
| Y-mAbs Therapeutics Inc | 119.90M |
| Akero Therapeutics Inc | 825.89M |
| Recursion Pharmaceuticals Inc | 1.449B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 656.51M |
| Shareholders Equity (Quarterly) | 228.54M |
| Debt to Equity Ratio | 1.981 |
| Current Ratio | 4.253 |
| Net Debt Paydown Yield | -1.81% |